摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

12,13-dihydro-11,13-dioxo-12-phenyl-9H,11H-pyrimido<4,3-c>pyrrolo<1,2-a><1,4>benzodiazepine | 154227-80-2

中文名称
——
中文别名
——
英文名称
12,13-dihydro-11,13-dioxo-12-phenyl-9H,11H-pyrimido<4,3-c>pyrrolo<1,2-a><1,4>benzodiazepine
英文别名
10-Phenyl-2,10,12-triazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,5,7,14,16-hexaene-9,11-dione
12,13-dihydro-11,13-dioxo-12-phenyl-9H,11H-pyrimido<4,3-c>pyrrolo<1,2-a><1,4>benzodiazepine化学式
CAS
154227-80-2
化学式
C21H15N3O2
mdl
——
分子量
341.369
InChiKey
OMLBMEBANPAEBV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    26
  • 可旋转键数:
    1
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    45.6
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    12,13-dihydro-11,13-dioxo-12-phenyl-9H,11H-pyrimido<4,3-c>pyrrolo<1,2-a><1,4>benzodiazepine 在 palladium on activated charcoal 氢气 作用下, 以 乙醇 为溶剂, 50.0 ℃ 、344.73 kPa 条件下, 反应 6.0h, 以92%的产率得到11,13-dioxo-12-phenyl-12,13,14,14a-tetrahydro-9H,11H-pyrimido<4,3-c>pyrrolo<1,2-a><1,4>benzodiazepine
    参考文献:
    名称:
    5,6-二氢-4 H-吡咯并[1,2- a ] [1,4]苯并二氮杂-4,4-二乙酸二乙酯,一种有用的合成子,可用于合成具有药理作用的新型多环氮系统
    摘要:
    该报告描述了两个氮四环系统的衍生物的合成,分别为9 H,11 H-嘧啶[4,3- c ]吡咯并[1,2- a ] [1,4]苯并二氮杂和螺[哌啶-4,通过使用5,6-二氢-4 H-吡咯并[1,2- a ] [的二乙酯] 4'-[4 H ]吡咯并[1,2- a ] [1,4]-苯并二氮杂] 1,4]苯并二氮杂-4,4-二乙酸作为合成子。由1-(2-氨基甲基苯基)-1的缩合获得该化合物ħ-吡咯与1,3-丙酮二羧酸二乙酯在酸性介质中的作用。在金属钠存在下,在沸腾的乙醚中用苯基异氰酸酯处理吡咯并苯并二氮杂卓4,4-二乙酸酯或相关的4-甲基-4-乙酸酯,即可得到嘧啶并吡咯并苯并二氮杂卓衍生物。12,13-dihydro-11,13-dioxo-12-phenyl-9 H,11 H -pyrimido [4,3- c ] pyrrolo [1,2- a ] [1,4]苯并二氮杂,的结构当5,6-二氢-4
    DOI:
    10.1002/jhet.5570300409
  • 作为产物:
    参考文献:
    名称:
    5,6-二氢-4 H-吡咯并[1,2- a ] [1,4]苯并二氮杂-4,4-二乙酸二乙酯,一种有用的合成子,可用于合成具有药理作用的新型多环氮系统
    摘要:
    该报告描述了两个氮四环系统的衍生物的合成,分别为9 H,11 H-嘧啶[4,3- c ]吡咯并[1,2- a ] [1,4]苯并二氮杂和螺[哌啶-4,通过使用5,6-二氢-4 H-吡咯并[1,2- a ] [的二乙酯] 4'-[4 H ]吡咯并[1,2- a ] [1,4]-苯并二氮杂] 1,4]苯并二氮杂-4,4-二乙酸作为合成子。由1-(2-氨基甲基苯基)-1的缩合获得该化合物ħ-吡咯与1,3-丙酮二羧酸二乙酯在酸性介质中的作用。在金属钠存在下,在沸腾的乙醚中用苯基异氰酸酯处理吡咯并苯并二氮杂卓4,4-二乙酸酯或相关的4-甲基-4-乙酸酯,即可得到嘧啶并吡咯并苯并二氮杂卓衍生物。12,13-dihydro-11,13-dioxo-12-phenyl-9 H,11 H -pyrimido [4,3- c ] pyrrolo [1,2- a ] [1,4]苯并二氮杂,的结构当5,6-二氢-4
    DOI:
    10.1002/jhet.5570300409
点击查看最新优质反应信息

文献信息

  • 5,6-Dihydro-4<i>H</i>-pyrrolo[1,2-<i>a</i>][1,4]benzodiazepine-4,4-diacetic acid diethyl ester, an useful synthon for the synthesis of new polycyclic nitrogen systems of pharmacological interest
    作者:Silvio Massa、Antonello Mai、Roberto Di Santo、Marino Artico
    DOI:10.1002/jhet.5570300409
    日期:1993.7
    This report describes the synthesis of derivatives of two nitrogen tetracyclic ring systems, respectively 9H,11H-pyrimido[4,3-c]pyrrolo[1,2-a][1,4]benzodiazepine and spiro[piperidine-4,4′-[4H]pyrrolo[1,2-a][1,4]-benzodiazepine], by the use of the diethyl ester of 5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzodiazepine-4,4-diacetic acid as a synthon. This compound was obtained by condensation of 1-(2-amin
    该报告描述了两个氮四环系统的衍生物的合成,分别为9 H,11 H-嘧啶[4,3- c ]吡咯并[1,2- a ] [1,4]苯并二氮杂和螺[哌啶-4,通过使用5,6-二氢-4 H-吡咯并[1,2- a ] [的二乙酯] 4'-[4 H ]吡咯并[1,2- a ] [1,4]-苯并二氮杂] 1,4]苯并二氮杂-4,4-二乙酸作为合成子。由1-(2-氨基甲基苯基)-1的缩合获得该化合物ħ-吡咯与1,3-丙酮二羧酸二乙酯在酸性介质中的作用。在金属钠存在下,在沸腾的乙醚中用苯基异氰酸酯处理吡咯并苯并二氮杂卓4,4-二乙酸酯或相关的4-甲基-4-乙酸酯,即可得到嘧啶并吡咯并苯并二氮杂卓衍生物。12,13-dihydro-11,13-dioxo-12-phenyl-9 H,11 H -pyrimido [4,3- c ] pyrrolo [1,2- a ] [1,4]苯并二氮杂,的结构当5,6-二氢-4
查看更多

同类化合物

阿斯普尼辛B 阿斯普尼辛 D 阿斯普尼辛 苯佐莫文 新骏河毒素 乙酰胺,N-(4-硝基-2-吡啶基)-,氧化(9CI) TAK960抑制剂 PLK1抑制剂(RO3280) 8H-嘧啶并[4,5-b][1,4]二氮杂卓 8-甲基-5,9-二氢-6H-嘧啶并[4,5-b][1,4]重氮基庚英-6-酮 6H-嘧啶并[4,5-b][1,4]二氮杂卓 4-甲基-6,11-二氢-3H-嘧啶并[4,5-b][1,5]苯并二氮杂卓-2,5-二酮 2-氯-7,7-二氟-5-甲基-5,7,8,9-四氢-6H-嘧啶基[4,5-B][1,4]二氮杂-6-酮 2-氯-5-甲基-5,7,8,9-四氢-6H-嘧啶[4,5-B][1,4]二氮杂6-酮 1H-嘧啶并[4,5-b][1,4]二氮杂卓 4-amino-8-(1,3-benzodioxol-5-yl)-6-phenyl-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepine 2-(2-Bromo-4-isopropyl-phenyl)-4-methyl-6-pentyl-6,7,8,9-tetrahydro-2H-2,3,5,6,9a-pentaaza-benzo[cd]azulen-1-one 2-chloro-8-(trifluoromethyl)-6H,11H-benzo[b]pyrimidino[5,4-f]-1,4-diazaperhydroepin-5-one 4,5,6,7-tetrahydro-2,4-diphenyl-4,7a,12b-triazadibenzo[e,g]azulene-1,3,8-trione 4,5,6,7-tetrahydro-4-methyl-2-phenyl-4,7a,12b-triazadibenzo[e,g]azulene-1,3,8-trione N-(4-((8,9-dimethoxy-5-methyl-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-11H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-5-methyl-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6-oxo-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-fluorophenyl)-N-(4-((8-methoxy-2-methyl-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6-oxo-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-fluorophenyl)-N-(4-((8-methoxy-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-11H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide di-tert-butyl (1r,4r)-4-(4-(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxybenzamido)cyclohexyl phosphate 2-(2-Bromo-4-isopropyl-phenyl)-6-(1-ethyl-propyl)-4-methyl-6,7,8,9-tetrahydro-2H-2,3,5,6,9a-pentaaza-benzo[cd]azulen-1-one 7,8,9,10-tetrahydro-10-hydroxy-9-heptyl-[1,4]diazepino[1,2,3-g,h]purine 7,8,9,10-tetrahydro-10-hydroxy-9-methyl-9-propyl[1,4]diazepino[1,2,3-g,h]purine 6-cyclopentyl-9-[(3-methoxyphenyl)amino]-2-methyl-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-3-one 6-cyclopentyl-9-[(2-methoxyphenyl)amino]-2-methyl-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-3-one tert-butyl 8,10-dibromo-7-oxo-1,2,5,5a,6,7-hexahydro-[1,4]diazepino[1,7-a]quinazoline-3(4H)-carboxylate tert-butyl 8,10-dimethyl-7-oxo-1,2,5,5a,6,7-hexahydro-[1,4]diazepino[1,7-a]quinazoline-3(4H)-carboxylate 11-Diallylaminoacetyl-6-isopropyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one 6-butyl-11-diallylaminoacetyl-2-phenyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one 11-chloroacetyl-6-isopropyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one 4-[(2-cyclopentyl-4,4,6-trimethyl-5-oxo-2,6,9,11-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-10-yl)amino]benzoic acid 4-[(2-cyclopentyl-6-methyl-5-oxo-2,6,9,11-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-10-yl)amino]-3-methoxy-N-(4-piperidyl)benzamide 4-[(6-cyclopentyl-2-methyl-3-oxo-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-9-yl)amino]-N-(1-ethyl-4-piperidyl)-3-methoxy-benzamide 8-(4-chlorophenyl)-6-phenyl-9H-pyrimido[4,5-b][1,4]diazepin-4-ol 1-chloro-7-methoxy-8-(3-morpholin-4-yl-propoxy)-10,11-dihydro-5H-2,4,5,11-tetraaza-dibenzo[a,d]cycloheptene 4-[(6-cyclopentyl-2-methyl-3-oxo-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-9-yl)amino]-3-methoxy-N-methyl-benzamide (S)-tert-butyl (4-chloro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-7-yl)carbamate 3-methoxy-4-[[6-(2-methoxyethyl)-2-methyl-3-oxo-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-9-yl]amino]-N-(1-methyl-4-piperidyl)benzamide (9aS,9R)-4-chloro-N-(4-methylphenyl)-9a,10,11,12-tetrahydro-9H-pyrimido[4,5-b]dipyrrolo[1,2-d:2',1'-g][1,4]diazepin-9-amine